Ghost Tree Capital’s Xenon Pharmaceuticals XENE Stock Holding History

Ghost Tree Capital’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-98,951	Closed	-$3.38M	–	77
2023 Q3	$3.38M	Sell	98,951 -86,049	-47%	-$3.22M	1.11%	32
2023 Q2	$7.12M	Sell	185,000 -15,000	-8%	-$596K	2.35%	17
2023 Q1	$7.16M	Buy	+200,000	New	+$7.39M	2.12%	19
2022 Q2	–	Sell	-100,000	Closed	-$3.06M	–	46
2022 Q1	$3.06M	Hold	100,000	–	–	0.66%	28
2021 Q4	$3.12M	Sell	100,000 -690,000	-87%	-$20.6M	1.12%	36
2021 Q3	$12.1M	Sell	790,000 -60,000	-7%	-$1.04M	3.53%	7
2021 Q2	$15.8M	Hold	850,000	–	–	4.35%	5
2021 Q1	$15.2M	Buy	850,000 +150,000	+21%	+$2.54M	3.58%	9
2020 Q4	$10.8M	Buy	700,000 +375,000	+115%	+$4.39M	2.4%	19
2020 Q3	$3.6M	Hold	325,000	–	–	1.04%	30
2020 Q2	$4.08M	Hold	325,000	–	–	1.08%	32
2020 Q1	$3.69M	Buy	+325,000	New	+$4.63M	0.98%	24
2017 Q2	–	Sell	-150,000	Closed	-$600K	–	78
2017 Q1	$600K	Sell	150,000 -175,000	-54%	-$1.38M	0.11%	63
2016 Q4	$2.5M	Hold	325,000	–	–	0.6%	52
2016 Q3	$2.63M	Buy	+325,000	New	+$2.51M	0.43%	62
2015 Q3	–	Sell	-37,500	Closed	-$432K	–	94
2015 Q2	$432K	Buy	+37,500	New	+$518K	0.14%	67

Other funds holding XENE

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ghost Tree Capital's XENE Position: Q4 2023 in Review

Ghost Tree Capital sold out of Xenon Pharmaceuticals (XENE) in Q4 2023, closing a stake of 98,951 shares — an estimated $3.38M sold.

Ghost Tree Capital first reported a position in XENE in Q2 2015 and held it in 16 quarters. The position peaked at $15.8M in Q2 2021. 204 funds tracked by Wall St. Rank hold XENE as of Q4 2023.

Ghost Tree Capital reported no remaining Xenon Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Ghost Tree Capital sold 98,951 Xenon Pharmaceuticals shares in Q4 2023, an estimated $3.38M.
Ghost Tree Capital first reported a position in Xenon Pharmaceuticals in Q2 2015 and held it in 16 quarters.
Ghost Tree Capital's Xenon Pharmaceuticals position peaked at $15.8M in Q2 2021.
204 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q4 2023.

Based on Ghost Tree Capital's 13F filing for Q4 2023, filed 14 Feb 2024.